Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study

• Robert Carreras-Torres,

  Affiliation Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France

  ⨯
• Mattias Johansson,

  Affiliation Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France

  ⨯
• Philip C. Haycock,

  Affiliation MRC Integrative Epidemiology Unit, School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom

  ⨯
• Kaitlin H. Wade,

  Affiliation MRC Integrative Epidemiology Unit, School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom

  ⨯
• Caroline L. Relton,

  Affiliation MRC Integrative Epidemiology Unit, School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom

  ⨯
• Richard M. Martin,

  Affiliations MRC Integrative Epidemiology Unit, School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom, National Institute for Health Research Biomedical Research Unit in Nutrition, Diet and Lifestyle at University Hospitals Bristol NHS Foundation Trust and the University of Bristol, Bristol, United Kingdom

  ⨯
• George Davey Smith,

  Affiliation MRC Integrative Epidemiology Unit, School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom

  ⨯
• Demetrius Albanes,

  Affiliation Metabolic Epidemiology Branch, DCEG, National Cancer Institute, NIH, Rockville, Maryland, United States of America

  ⨯
• Melinda C. Aldrich,

  Affiliation Department of Thoracic Surgery, Division of Epidemiology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

  ⨯
• Angeline Andrew,

  Affiliation Norris Cotton Cancer Center, Lebanon, New Hampshire, United States of America

  ⨯
• Susanne M. Arnold,

  Affiliation University of Kentucky Markey Cancer Center, Lexington, Kentucky, United States of America

  http://orcid.org/0000-0001-6542-9551

  ⨯
• Heike Bickeböller,

  Affiliation University Medical Center Göettingen, Göttingen, Germany

  ⨯
• Stig E. Bojesen,

  Affiliation Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Hans Brunnström,

  Affiliation Laboratory Medicine Region Skåne, Department of Clinical Sciences Lund, Lund University, Lund, Sweden

  ⨯
• Jonas Manjer,

  Affiliation Laboratory Medicine Region Skåne, Department of Clinical Sciences Lund, Lund University, Lund, Sweden

  ⨯
• Irene Brüske,

  Affiliation Helmholtz Zentrum München, Munich, Germany

  ⨯
• Neil E. Caporaso,

  Affiliation Genetic Epidemiology Branch, DCEG, National Cancer Institute, NIH, Rockville, Maryland, United States of America

  ⨯
• Chu Chen,

  Affiliation Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• David C. Christiani,

  Affiliation Departments of Environmental Health and Epidemiology, Harvard T. H. Chan School of Public Health and Department of Medicine, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• W. Jay Christian,

  Affiliation Department of Epidemiology, College of Public Health, University of Kentucky, Lexington, Kentucky, United States of America

  ⨯
• Jennifer A. Doherty,

  Affiliation Department of Epidemiology, Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire, United States of America

  ⨯
• Eric J. Duell,

  Affiliation Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain

  ⨯
• John K. Field,

  Affiliation Roy Castle Lung Cancer Research Programme, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, The University of Liverpool, Liverpool, United Kingdom

  http://orcid.org/0000-0003-3951-6365

  ⨯
• Michael P. A. Davies,

  Affiliation Roy Castle Lung Cancer Research Programme, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, The University of Liverpool, Liverpool, United Kingdom

  http://orcid.org/0000-0002-7609-4977

  ⨯
• Michael W. Marcus,

  Affiliation Roy Castle Lung Cancer Research Programme, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, The University of Liverpool, Liverpool, United Kingdom

  http://orcid.org/0000-0003-3133-4284

  ⨯
• Gary E. Goodman,

  Affiliation Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Kjell Grankvist,

  Affiliation Department of Medical Biosciences, Umeå University, Umeå, Sweden

  ⨯
• Aage Haugen,

  Affiliation National Institute of Occupational Health, Oslo, Norway

  ⨯
• Yun-Chul Hong,

  Affiliation Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea

  ⨯
• Lambertus A. Kiemeney,

  Affiliation Radboud University Medical Center, Nijmegen, The Nederlands

  http://orcid.org/0000-0002-2368-1326

  ⨯
• Erik H. F. M. van der Heijden,

  Affiliation Radboud University Medical Center, Nijmegen, The Nederlands

  http://orcid.org/0000-0003-3596-518X

  ⨯
• Peter Kraft,

  Affiliation Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America

  http://orcid.org/0000-0002-4472-8103

  ⨯
• Mikael B. Johansson,

  Affiliation Department of Medical Biosciences, Umeå University, Umeå, Sweden

  ⨯
• Stephen Lam,

  Affiliation British Columbia Cancer Agency, Vancouver, British Columbia, Canada

  ⨯
• Maria Teresa Landi,

  Affiliation Genetic Epidemiology Branch, DCEG, National Cancer Institute, NIH, Rockville, Maryland, United States of America

  ⨯
• Philip Lazarus,

  Affiliation Washington State University College of Pharmacy, Spokane, Washington, United States of America

  ⨯
• Loïc Le Marchand,

  Affiliation Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, United States of America

  ⨯
• Geoffrey Liu,

  Affiliation Ontario Cancer Institute, Princess Margaret Cancer Center, Toronto, Ontario, Canada

  ⨯
• Olle Melander,

  Affiliations Department of Clinical Sciences Malmö, Lund University, Lund, Sweden, Department of Internal Medicine, Skåne University Hospital, Malmö, Sweden

  ⨯
• Sungshim L. Park,

  Affiliation Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America

  http://orcid.org/0000-0003-2818-4705

  ⨯
• Gad Rennert,

  Affiliation Clalit National Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel

  ⨯
• Angela Risch,

  Affiliation University of Salzburg and Cancer Cluster Salzburg, Salzburg, Austria

  ⨯
• Eric B. Haura,

  Affiliation Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America

  ⨯
• Ghislaine Scelo,

  Affiliation Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France

  ⨯
• David Zaridze,

  Affiliation Russian N.N. Blokhin Cancer Research Centre, Moscow, The Russian Federation

  ⨯
• Anush Mukeriya,

  Affiliation Russian N.N. Blokhin Cancer Research Centre, Moscow, The Russian Federation

  ⨯
• Milan Savić,

  Affiliation Department of Thoracic Surgery, Clinical Center of Serbia, Belgrade, Serbia

  ⨯
• Jolanta Lissowska,

  Affiliation Department of Cancer Epidemiology and Prevention, Maria Sklodowska-Curie Institute – Oncology Center, Warsaw, Poland

  ⨯
• Beata Swiatkowska,

  Affiliation Nofer Institute of Occupational Medicine, Department of Environmental Epidemiology, Lodz, Poland

  ⨯
• Vladimir Janout,

  Affiliation Department of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic

  ⨯
• Ivana Holcatova,

  Affiliation Institute of Public Health and Preventive Medicine, Charles University, 2nd Faculty of Medicine, Prague, Czech Republic

  ⨯
• Dana Mates,

  Affiliation National Institute of Public Health, Bucharest, Romania

  ⨯
• Matthew B. Schabath,

  Affiliation Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America

  http://orcid.org/0000-0003-3241-3216

  ⨯
• Hongbing Shen,

  Affiliation Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China

  ⨯
• Adonina Tardon,

  Affiliation Instituto Universitario de Oncología del Principado de Asturias (IUOPA), University of Oviedo and CIBERESP, Oviedo, Spain

  ⨯
• M Dawn Teare,

  Affiliation University of Sheffield, Sheffield, United Kingdom

  http://orcid.org/0000-0003-3994-0051

  ⨯
• Penella Woll,

  Affiliation University of Sheffield, Sheffield, United Kingdom

  ⨯
• Ming-Sound Tsao,

  Affiliation Princess Margaret Cancer Center, Toronto, Canada

  ⨯
• Xifeng Wu,

  Affiliation The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Jian-Min Yuan,

  Affiliation Division of Cancer Control and Population Science, University of Pittsburgh Cancer Institute; and Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, United States of America

  ⨯
• Rayjean J. Hung,

  Affiliation Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada

  ⨯
• Christopher I. Amos,

  Affiliation Department of Biomedical Data Science, Geisel School of medicine, Dartmouth College, Lebanon, New Hampshire, United States of America

  ⨯
• James McKay,

  Affiliation Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France

  http://orcid.org/0000-0002-1787-3874

  ⨯
•  [ ... ],
• Paul Brennan

  * E-mail: gep@iarc.fr

  Affiliation Section of Genetics, International Agency for Research on Cancer (IARC), Lyon, France

  ⨯
• [ view all ]
• [ view less ]